Author: United States. Food and Drug Administration
Publisher:
ISBN:
Category :
Languages : en
Pages : 20
Book Description
FDA 1961
Author: United States. Food and Drug Administration
Publisher:
ISBN:
Category :
Languages : en
Pages : 20
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 20
Book Description
A Legislative History of the Federal Food, Drug, and Cosmetic Act and Its Amendments
Author: United States
Publisher:
ISBN:
Category : Cosmetics
Languages : en
Pages : 892
Book Description
Publisher:
ISBN:
Category : Cosmetics
Languages : en
Pages : 892
Book Description
Drug Industry Act of 1962
Author: United States. Congress. House. Committee on Interstate and Foreign Commerce
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 728
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 728
Book Description
Interagency Coordination in Drug Research and Regulations
Author: United States. Congress. Senate. Government Operations
Publisher:
ISBN:
Category :
Languages : en
Pages : 1332
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 1332
Book Description
A Legislative History of the Federal Food, Drug, and Cosmetic Act and Its Amendments
FDA Nutrition Labeling Manual
Author: United States. Food and Drug Administration
Publisher:
ISBN:
Category : Database design
Languages : en
Pages : 152
Book Description
Gives generic instructions for developing and preparing an acceptable data base when valid estimates of nutrient content and variation are not available for the food (single or mixed products) to be labeled. The purpose of the manual is to advise the food industry in developing nutrition labels for food products that must comply with the regulations and to assist health professionals in interpreting nutrition labels on food products.
Publisher:
ISBN:
Category : Database design
Languages : en
Pages : 152
Book Description
Gives generic instructions for developing and preparing an acceptable data base when valid estimates of nutrient content and variation are not available for the food (single or mixed products) to be labeled. The purpose of the manual is to advise the food industry in developing nutrition labels for food products that must comply with the regulations and to assist health professionals in interpreting nutrition labels on food products.
Interagency Coordination in Drug Research and Regulation: Supplementary exhibits and index to parts 1 and 2
Author: United States. Congress. Senate. Committee on Government Operations
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 484
Book Description
Reviews cooperative efforts among Federal and international agencies responsible for medical research on experimental drugs and regulation of pharmaceutical industry marketing practices. Includes review of thalidomide marketing and use, drugs for mental illness, neonatal pharmacology, etc.
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 484
Book Description
Reviews cooperative efforts among Federal and international agencies responsible for medical research on experimental drugs and regulation of pharmaceutical industry marketing practices. Includes review of thalidomide marketing and use, drugs for mental illness, neonatal pharmacology, etc.
Interagency Coordination in Drug Research and Regulation
Author: United States. Congress. Senate. Committee on Government Operations
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 504
Book Description
Reviews cooperative efforts among Federal and international agencies responsible for medical research on experimental drugs and regulation of pharmaceutical industry marketing practices. Includes review of thalidomide marketing and use.
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 504
Book Description
Reviews cooperative efforts among Federal and international agencies responsible for medical research on experimental drugs and regulation of pharmaceutical industry marketing practices. Includes review of thalidomide marketing and use.
Reputation and Power
Author: Daniel Carpenter
Publisher: Princeton University Press
ISBN: 1400835119
Category : Political Science
Languages : en
Pages : 825
Book Description
How the FDA became the world's most powerful regulatory agency The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industry as powerful as American pharmaceuticals while resisting efforts to curb its own authority. Carpenter explains how the FDA's reputation and power have played out among committees in Congress, and with drug companies, advocacy groups, the media, research hospitals and universities, and governments in Europe and India. He shows how FDA regulatory power has influenced the way that business, medicine, and science are conducted in the United States and worldwide. Along the way, Carpenter offers new insights into the therapeutic revolution of the 1940s and 1950s; the 1980s AIDS crisis; the advent of oral contraceptives and cancer chemotherapy; the rise of antiregulatory conservatism; and the FDA's waning influence in drug regulation today. Reputation and Power demonstrates how reputation shapes the power and behavior of government agencies, and sheds new light on how that power is used and contested. Some images inside the book are unavailable due to digital copyright restrictions.
Publisher: Princeton University Press
ISBN: 1400835119
Category : Political Science
Languages : en
Pages : 825
Book Description
How the FDA became the world's most powerful regulatory agency The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industry as powerful as American pharmaceuticals while resisting efforts to curb its own authority. Carpenter explains how the FDA's reputation and power have played out among committees in Congress, and with drug companies, advocacy groups, the media, research hospitals and universities, and governments in Europe and India. He shows how FDA regulatory power has influenced the way that business, medicine, and science are conducted in the United States and worldwide. Along the way, Carpenter offers new insights into the therapeutic revolution of the 1940s and 1950s; the 1980s AIDS crisis; the advent of oral contraceptives and cancer chemotherapy; the rise of antiregulatory conservatism; and the FDA's waning influence in drug regulation today. Reputation and Power demonstrates how reputation shapes the power and behavior of government agencies, and sheds new light on how that power is used and contested. Some images inside the book are unavailable due to digital copyright restrictions.
Interagency Coordination in Drug Research and Regulation: The Bureau of Medicine in the Food and Drug Administration
Author: United States. Congress. Senate. Committee on Government Operations
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 512
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 512
Book Description